May 22, 2017 1:51 PM ET

Healthcare Equipment and Supplies

Company Overview of Arch Therapeutics, Inc.

Company Overview

Arch Therapeutics, Inc. operates as a life science medical device company. The company develops products based on its technology to stop bleeding and control leaking, as well as provides other advantages during surgery and trauma care. Its primary product candidate is AC5 Devices, a biocompatible synthetic peptide that comprises naturally occurring amino acids to achieve hemostasis in minimally invasive and open surgical procedures. The company was founded in 2006 and is based in Framingham, Massachusetts.

235 Walnut Street

Suite 6

Framingham, MA 01702

United States

Founded in 2006

6 Employees

Phone:

617-431-2313

Key Executives for Arch Therapeutics, Inc.

Co-Founder, Chief Executive Officer, President and Director
Age: 51
Total Annual Compensation: $422.5K
Chief Financial Officer and Treasurer
Age: 58
Total Annual Compensation: $328.1K
Compensation as of Fiscal Year 2016.

Arch Therapeutics, Inc. Key Developments

Arch Therapeutics, Inc. Presents at Maxim Group - Haitong Securities Healthcare Investor and Partnering Conference, Mar-06-2017 03:30 PM

Arch Therapeutics, Inc. Presents at Maxim Group - Haitong Securities Healthcare Investor and Partnering Conference, Mar-06-2017 03:30 PM. Venue: Park Hyatt Shanghai, Shanghai, China. Speakers: Terrence W. Norchi, Co-Founder, Chief Executive Officer, President and Director.

Arch Therapeutics, Inc. Presents at 29th Annual ROTH Conference, Mar-13-2017 12:30 PM

Arch Therapeutics, Inc. Presents at 29th Annual ROTH Conference, Mar-13-2017 12:30 PM. Venue: The Ritz Carlton, Laguna Niguel, Dana Point, California, United States. Speakers: Terrence W. Norchi, Co-Founder, Chief Executive Officer, President and Director.

Arch Therapeutics Mulls Acquisitions

Arch Therapeutics, Inc. (OTCPK:ARTH) is looking for acquisition opportunities. The net proceeds from the sale of the securities will be used for working capital and general corporate purposes, which may include acquisitions, retirement of debt and other business opportunities.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 24, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Arch Therapeutics, Inc., please visit www.archtherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.